PODD
Insulet Corp.Healthcare · $9.2B market cap
Verdict
Share price
$131.69
close of Oct 3, 2026
Fair value
$62.06
Sticker Price
Payback Price
$24.82
buy price
PODD is Overpriced: at $131.69 it trades 112% above its fair value of $62.06. Its buy price (Payback Price) is $24.82, 81% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
4 of 5 clear the 10% bar. What are the Big Five?
Follow PODD
Get notified when it reaches its buy price of $24.82. Free.
Create a free accountInsider activity
Since Jun 30, 2026: 1 open-market purchase worth $162K and 4 other filings (stock awards, tax withholding and similar). Why purchases matter
Purchases
Other filings
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values…
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works